يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Brandy Box-Noriega"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)

    المؤلفون: Mario R. Velasco, Charles Lu, Mary W. Redman, James Gilbert Hueftle, Jieling Miao, Ignacio I. Wistuba, David R. Gandara, Nicholas J. Vogelzang, Shirish M. Gadgeel, Frank V. Fossella, John V. Heymach, Brandy Box-Noriega, Anne S. Tsao, Karen Kelly

    المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 37, iss 28

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Mesothelioma, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, SWOG investigators, Pleural Neoplasms, Oncology and Carcinogenesis, Clinical Sciences, and over, Pemetrexed, law.invention, Cediranib, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, 80 and over, Humans, Progression-free survival, Oncology & Carcinogenesis, Aged, Cisplatin, Aged, 80 and over, Chemotherapy, Malignant, business.industry, Mesothelioma, Malignant, ORIGINAL REPORTS, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Quinazolines, Female, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8747aaffb359ac72c1ac8b684af4b6cTest
    https://pubmed.ncbi.nlm.nih.gov/31386610Test


    أضف إلى المفضلة
  2. 2
    Phase II Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemo Naive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905, NCT01064648)

    المؤلفون: Karen Kelly, David R. Gandara, Jieling Miao, Brandy Box-Noriega, Mary W. Redman, James Gilbert Hueftle, Ignacio I. Wistuba, Frank Fossella, Shirish M. Gadgeel, Charles Lu, Mario R. Velasco, Nicholas J. Vogelzang, J. Heymach, Anne Tsao

    المصدر: SSRN Electronic Journal.

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer prevention, business.industry, medicine.disease, law.invention, Cediranib, Pemetrexed, Randomized controlled trial, Cancer Therapy Evaluation Program, Informed consent, law, Internal medicine, medicine, Clinical endpoint, Mesothelioma, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::41ed2740da60e619667bdd6bf3e99697Test
    https://doi.org/10.2139/ssrn.3254484Test


    أضف إلى المفضلة
  3. 3
    SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma

    المؤلفون: Nicholas J. Vogelzang, Mary W. Redman, James Gilbert Hueftle, Charles Lu, Shirish M. Gadgeel, Jieling Miao, Ignacio I. Wistuba, Frank V. Fossella, Mario R. Velasco, John V. Heymach, Anne S. Tsao, David R. Gandara, Brandy Box-Noriega, Karen Kelly

    المصدر: Journal of Clinical Oncology. 36:8514-8514

    مصطلحات موضوعية: Cisplatin, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pleural mesothelioma, Phases of clinical research, respiratory system, Placebo, respiratory tract diseases, Cediranib, 03 medical and health sciences, 0302 clinical medicine, Pemetrexed, 030228 respiratory system, 030220 oncology & carcinogenesis, Internal medicine, Medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4254684a288cae39303bd71bb10e2f4bTest
    https://doi.org/10.1200/jco.2018.36.15_suppl.8514Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث